Get started
Author

Gulmira Ismailovna Kalmambetova

Observed names: G. Kalmambetova, Gulmira Kalmambetova, Kalmambetova Gulmira, Kalmambetova, Gulmira, Г.И. Калмамбетова
Observed institution: Ministry of Health of Kyrgyzstan
ORCID: 0000-0002-0428-5539
Observed ORCID: 0000-0002-0428-5539
OpenAlex ID: A5011245870
Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country
2021 · Monica Vogel, Christian Utpatel, et al. · Scientific Reports · 38
PDF
Diagnostic accuracy of the Xpert® MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis
2017 · B. Lange, P. Khan, et al. · The International Journal of Tuberculosis and Lung Disease · 32
Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred services
2019 · Masoud Dara, Soudeh Ehsani, et al. · The Lancet Infectious Diseases · 26
Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia
2019 · Anna Engström, Uladzimir Antonenka, et al. · BMC Infectious Diseases · 26
PDF
Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020
2021 · Florian P Maurer, Natalia Shubladze, et al. · Eurosurveillance · 17
Integrated use of laboratory services for multiple infectious diseases in the WHO European Region during the COVID-19 pandemic and beyond
2022 · Daniel Simões, Soudeh Ehsani, et al. · Eurosurveillance · 10
PDF
Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus
2020 · Caroline Corbett, Aizat Kulzhabaeva, et al. · BMC Infectious Diseases · 10
PDF
Sex differences in risk factors for unsuccessful tuberculosis treatment outcomes in Eastern Europe from 2020 to 2022: a multi-country retrospective cohort study
2025 · Ole Skouvig Pedersen, Tetiana Butova, et al. · The Lancet Regional Health - Europe · 9
PDF
Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis
2019 · S. Hofmann-Thiel, N. Molodtsov, et al. · The International Journal of Tuberculosis and Lung Disease · 9
Results of Xpert® MTB/RIF implementation in Kyrgyzstan
2017 · G. Kurbaniyazova, M. Joncevska, et al. · The International Journal of Tuberculosis and Lung Disease · 9
Drug-Resistant Tuberculosis, Georgia, Kazakhstan, Kyrgyzstan, Moldova, and Ukraine, 2017–2022
2024 · Victor Naestholt Dahl, Tetiana Butova, et al. · Emerging infectious diseases · 8
PDF
Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region
2022 · Florian P. Maurer, Natalia Shubladze, et al. · Journal of Molecular Diagnostics · 8
PDF
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis
2024 · Daniela Cirillo, Richard Anthony, et al. · The Lancet Global Health · 7
Stigmatization and discrimination of female tuberculosis patients in Kyrgyzstan – a phenomenological study
2025 · Rhea Brüggemann, Fabian Schlumberger, et al. · International Journal for Equity in Health · 6
PDF
Quality of Electronic TB Register Data Compared with Paper-Based Records in the Kyrgyz Republic
2023 · Daniil Shauer, Ofelya Petrosyan, et al. · Tropical Medicine and Infectious Disease · 6
PDF
Lessons Learned from Early Implementation and Scale-up of Stool-Based Xpert Testing to Diagnose Tuberculosis in Children
2025 · Eveline Klinkenberg, Petra de Haas, et al. · Emerging infectious diseases · 4
Transmission of high-level drug-resistance mutations in HIV-1 subtype A6 circulating among former Soviet Union countries
2026 · Nurzhanna Bakuova, Anastasiia Nefedova, et al. · International Journal of Infectious Diseases · 2
PDF
Systematic investigation of baseline nosocomial transmission of tuberculosis in the Kyrgyz Republic, Central Asia
2025 · Harald Hoffmann, Christian Utpatel, et al. · Clinical Microbiology and Infection · 2
Whole-genome sequencing drug susceptibility testing is associated with positive MDR-TB treatment response
2024 · L. Larsson, C. Corbett, et al. · The International Journal of Tuberculosis and Lung Disease · 2
QuantiFERON-TB Gold plus testing for the detection of LTBI among health care workers in major TB hospitals of the Northern Kyrgyz Republic
2022 · Caroline Corbett, Gulmira Kalmambetova, et al. · BMC Infectious Diseases · 2
PDF
Further effort is needed to avoid irrational use after drug susceptibility testing for drug-resistant TB
2025 · L. Larsson, C. Corbett, et al. · The International Journal of Tuberculosis and Lung Disease · 1
Nanopore targeted sequencing for the detection of drug-resistant tuberculosis compared to standard of care drug susceptibility testing in Kyrgyzstan
2025 · Aizat Kulzhabaeva, Altyn Iskakova, et al.
Мониторинг оценки рисков биобезопасности в ла бораториях диагностики туберкулеза Кыргызской Республики
2025 · М.М. Сыдыкова, Г.И. Калмамбетова, et al. · Scientific and practical journal Healthcare of Kyrgyzstan
PDF
Evaluation of existing digital tools in national tuberculosis control programs of Armenia and Kyrgyzstan
2024 · Olga Hovardovska, Harald Hoffmann, et al.
Multidrug-resistant tuberculosis and treatment outcomes in Kazakhstan, Moldova, Ukraine, Georgia, and Kyrgyzstan
2024 · Tetiana Butova, Alex Rosenthal, et al.
Works count: 37
Citation count: 242
H-index: 9
I10-index: 7
Year
Topic
Type